血清sFas、sFasl水平與2型糖尿病患者認(rèn)知功能、抑郁狀態(tài)的相關(guān)性研究
[Abstract]:AIM: To investigate the serum levels of s Fas (soluble fas), s Fasl (soluble Fas ligand) in type 2 diabetes mellitus (T2DM) patients and healthy controls, and to use a repeatable Repeatable battery for the assessment of neuropsychological status (RBANS). Cognitive function of type 2 diabetes mellitus patients and healthy control group was assessed. Self-Rating Depression Scale (SDS) was used to assess depressive status of type 2 diabetes mellitus patients and healthy control group. The general data and biochemical indexes of type 2 diabetes mellitus patients were tested. Statistical analysis was conducted to investigate the changes of serum s Fas and s Fasl levels and their cognitive function, depression status in patients with type 2 diabetes mellitus, and to further explore the correlation between serum s Fas and s Fasl levels and cognitive function and depression status in patients with type 2 diabetes mellitus. Sixty-three patients with type 2 diabetes mellitus hospitalized in the Department of Endocrinology of Shandong Workers Hospital were divided into the case group and 68 patients with normal blood glucose and glycosylated hemoglobin were selected as the healthy control group. Fasting plasma glucose (FPG), glycosylated hemoglobin (Hb A1c), total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL-C), low-density lipoprotein (LDL-C) and other biochemical indicators. The case group was also fasting insulin (Fasting insulin, LDL-C). In, FINS was used to calculate the Homeostasis model assessment of insulin resistance (HOMA-IR). Serum levels of s Fas and s Fasl were measured and compared statistically. The cognitive function of the two groups was assessed according to the RBANS scale, and the self-rating depression scale (SDS) was used to compare the two groups. Result: 1. Comparison between case group and healthy control group. Results: The general data of two groups and clinical biochemical indexes were compared. Results: The levels of FPG, Hb A1C, TC, TG in case group were higher than those in healthy control group, HDL was higher. The level of serum s Fas and s Fasl in the case group was higher than that in the healthy control group, and the level of serum s Fasl was lower than that in the healthy control group, the difference was statistically significant (P 0.05). (See Table 2, Fig.6-Fig.7) Results: The scores of immediate memory, visual space, delayed memory and RBANS in the case group were lower than those in the healthy control group (P 0.05), but there was no significant difference in speech function and attention (P 0.05). (See Table 3, Fig.8-Fig.11) The results of correlation analysis and multiple stepwise regression analysis showed that: (1) The correlation analysis of serum s Fas and s Fasl levels with clinical biochemical indicators in case group: Serum s Fas levels were positively correlated with FINS, HOMA-IR, Hb A1c (P 0.05). Serum s Fasl levels were positively correlated with FPG, FI. NS, HOMA-IR was negatively correlated (P 0.05). (See Table 5) Multivariate stepwise regression analysis further showed that after correction for confounding factors, s Fasl was still positively correlated with HOMI-IR (t = 3.249, P = 0.002). s Fasl was negatively correlated with HOMA-IR (t = - 2.299, P = 0.025). (See Table 8-Table 9, Fig. 13-Fig. 14) Correlation analysis: Serum s Fasl level was negatively correlated with the sub-item visual space and the total score of the RBANS scale (P 0.05). Serum s Fasl level was positively correlated with the total score of the RBANS scale (P 0.05). (See Table 6). Further, the total score of cognitive function was calculated, and the results of multiple stepwise regression analysis showed that the sub-items and the other indicators were correlated. (1) The total score of RBANS was negatively correlated with HOMA-IR (t = - 3.61, P = 0.001), Age (t = - 2.65, P = 0.010), Fas s (t = - 2.309, P = 0.024). (see Table 10, Fig. 15-Fig. 16) (2) Immediatmemory and age (t = - 3.312, P = 0.312, P = 0.002), HOMA-IR (- 3.007, P = 0.007, P = 0.004) Ag (t = - 2.65, P = 0.010 0 0 0 0 0 0 0 0 0 0), Fas (t = - 2.309, P = 0.309, P = 0.024) Fas (see Table 10, Fig. 15 537, P = 0.014) was negatively correlated. Language function was negatively correlated with HOMA-IR (t =-2.905, P = 0.005). (5) Attention was negatively correlated with HOMA-IR (t =-3.534, P = 0.001), and was positively correlated with education (t = 2.321, P = 0.024). (6) Delayed memory was negatively correlated with HOMA-IR (t =-5.145, P = 0.001), age (t =-2.589, P = 0.012). 3. Fas s and Fas s levels were negatively correlated with serum SDS scores. Fas levels were positively correlated with SDS scores (P 0.05). (See Table 7) Multivariate stepwise regression analysis showed that SDS scores were positively correlated with HOMA-IR (t = 2.538, P = 0.014), Age (t = 2.759, P = 0.008), and s Fas (t = 3.062, P = 0.003). (See Table 11, Fig. 17-Fig. 18) Conclusion: Serum s Fas levels in type 2 diabetes mellitus were elevated and s Fas levels were positively correlated. The decrease of Fasl level indicates that there are abnormal changes in the s Fas/s Fasl system in type 2 diabetes mellitus. 2 Type 2 diabetes mellitus patients have cognitive impairment and are prone to depression. 3 Type 2 diabetes mellitus patients'serum s Fas level is closely related to cognitive impairment and depression.
【學(xué)位授予單位】:河北醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2015
【分類號(hào)】:R587.1
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 姚民秀;許愛梅;徐倩;劉加洪;商永芳;;sFas、sFasL與2型糖尿病關(guān)系的探討[J];山東醫(yī)藥;2007年08期
2 叢建妮;李革;雷迅;;自身免疫性甲狀腺疾病患者的尿碘與外周血sFas和sFasL的關(guān)系研究[J];廣東微量元素科學(xué);2009年11期
3 劉曉莉,張茂宏,彭軍;血清sFas、sFasL水平與特發(fā)性血小板減少性紫癜的關(guān)系[J];山東醫(yī)藥;2001年22期
4 林英輝;黃小琪;陳松林;陳晶;熊彪;;肺結(jié)核患者外周血中sFas、sFasL濃度檢測(cè)及其對(duì)預(yù)后的評(píng)估價(jià)值[J];現(xiàn)代預(yù)防醫(yī)學(xué);2011年14期
5 張艷華;盛光耀;李菡;;兒童特發(fā)性血小板減少性紫癜外周血中CD_(4)、CD_(28)、sFas和sFasL表達(dá)的臨床研究[J];河南職工醫(yī)學(xué)院學(xué)報(bào);2010年01期
6 曹樹軍;程國杰;崔亮;;急性心肌梗死合并糖尿病患者血清細(xì)胞凋亡因子sFas和sFasL的變化及意義[J];中國現(xiàn)代醫(yī)藥雜志;2008年07期
7 賈瑞萍;趙雪蕓;;自身免疫性血小板減少性紫癜患者外周血中CD4~+ CD25~+調(diào)節(jié)性T細(xì)胞、sFas和sFasL的表達(dá)及臨床意義[J];中國實(shí)驗(yàn)血液學(xué)雜志;2011年05期
8 張丁丁;伍敏婷;;過敏性紫癜患者sFas/sFasL、TNFα的變化及相關(guān)性研究[J];中國熱帶醫(yī)學(xué);2009年02期
9 余奇文,張勇,張冬青,李寧麗,馬安倫,周光炎;sFas、sFasL及細(xì)胞因子在類風(fēng)濕關(guān)節(jié)炎疾病中的意義[J];細(xì)胞與分子免疫學(xué)雜志;2001年02期
10 何建方,周建方,戴利成,施柏年,王偉紅,陸群英;慢性乙型肝炎患者治療前后血清sFas和sFasL的變化及其臨床意義[J];檢驗(yàn)醫(yī)學(xué);2005年01期
相關(guān)會(huì)議論文 前8條
1 劉加洪;王英年;張可佳;;肺結(jié)核患者外周血sFasL檢測(cè)的臨床意義[A];2005年中國防癆協(xié)會(huì)全國學(xué)術(shù)會(huì)議論文集[C];2005年
2 張艷華;盛光耀;鄒湘;方營旗;白松婷;王璐;;兒童特發(fā)性血小板減少性紫癜外周血中CD_4、CD_(28)、sFas和sFasL的表達(dá)及臨床意義[A];中華醫(yī)學(xué)會(huì)第三次全國兒科基層醫(yī)師學(xué)術(shù)會(huì)議論文匯編[C];2007年
3 林向陽;陳艷;;重癥乙型肝炎患者血清中sFas和sFasL水平的檢測(cè)[A];2004年浙江省檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2004年
4 宮希濤;劉加洪;王英年;;初治肺結(jié)核患者外周血sFas、sFasL測(cè)定的臨床意義研究[A];結(jié)核與肺部疾病論文集[C];2006年
5 崔海燕;張青;粟波;唐神結(jié);;細(xì)胞因子及sFasL在結(jié)核性胸膜炎免疫機(jī)制中的作用初探[A];中華醫(yī)學(xué)會(huì)結(jié)核病學(xué)分會(huì)2011年學(xué)術(shù)會(huì)議論文匯編[C];2011年
6 李德謙;梅長林;;尿毒癥患者血清sFas、sFasL水平與心血管疾病的關(guān)系[A];中華醫(yī)學(xué)會(huì)腎臟病學(xué)分會(huì)2006年學(xué)術(shù)年會(huì)論文集[C];2006年
7 王英年;劉加洪;孫榮麗;張可佳;官明德;于華;李黎;張春玲;;P-選擇素、IL-1α、sFas、sFasL、AM檢測(cè)對(duì)結(jié)核性與惡性胸腔積液鑒別診斷價(jià)值暨與CEA比較系列研究[A];結(jié)核與肺部疾病論文集[C];2005年
8 李寧麗;王利;余奇文;沈伯華;聶紅;張冬青;馮國璋;胡軍林;徐岳林;白朝暉;丁盛;戴號(hào);;RA患者SF中細(xì)胞因子與sFasL的病理意義[A];中國免疫學(xué)會(huì)第四屆學(xué)術(shù)大會(huì)會(huì)議議程及論文摘要集[C];2002年
相關(guān)碩士學(xué)位論文 前10條
1 于歡;血清sFas、sFasl水平與2型糖尿病患者認(rèn)知功能、抑郁狀態(tài)的相關(guān)性研究[D];河北醫(yī)科大學(xué);2015年
2 孫榮麗;sFas和sFasL對(duì)惡性與結(jié)核性胸腔積液鑒別診斷價(jià)值及臨床意義的研究[D];青島大學(xué);2005年
3 樊紅光;充血性心力衰竭患者血漿中sFas與sFasL的變化及其臨床意義[D];蘇州大學(xué);2002年
4 張艷華;兒童特發(fā)性血小板減少性紫癜外周血中CD_4、CD_(28)、sFas和sFasL的表達(dá)及臨床意義[D];鄭州大學(xué);2007年
5 蔣樂龍;人工肝支持系統(tǒng)對(duì)重型肝炎血清sFas、sFasL影響的研究[D];大連醫(yī)科大學(xué);2008年
6 姜洪偉;探討sFas、sFasL在乳腺癌中的表達(dá)及臨床意義[D];吉林大學(xué);2007年
7 李鳳瓊;母血、臍血中sFas/sFasL含量與不明原因FGR關(guān)系的初探[D];昆明醫(yī)學(xué)院;2008年
8 許彤;sFas和sFasL在乳腺癌新輔助化療過程中的臨床意義[D];浙江大學(xué);2015年
9 時(shí)鵬;急性腦梗死患者外周血sFas和sFasL水平觀察研究[D];安徽醫(yī)科大學(xué);2011年
10 劉加洪;外周血sFas、sFasL測(cè)定對(duì)預(yù)測(cè)糖尿病并發(fā)肺結(jié)核價(jià)值暨臨床意義的研究[D];青島大學(xué);2003年
,本文編號(hào):2205537
本文鏈接:http://sikaile.net/yixuelunwen/nfm/2205537.html